메뉴 건너뛰기




Volumn 60, Issue 2, 2014, Pages 679-686

Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ATORVASTATIN; BILIRUBIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

EID: 84904698842     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27157     Document Type: Article
Times cited : (189)

References (22)
  • 1
    • 84904690965 scopus 로고    scopus 로고
    • Accessed on January 4
    • www.drugtopics.com. Accessed on January 4, 2013.
    • (2013)
  • 2
    • 0037178569 scopus 로고    scopus 로고
    • Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention
    • Serruys PW, De Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention. JAMA 2002;287:3215-3222.
    • (2002) JAMA , vol.287 , pp. 3215-3222
    • Serruys, P.W.1    De Feyter, P.2    Macaya, C.3    Kokott, N.4    Puel, J.5    Vrolix, M.6
  • 3
    • 0035804846 scopus 로고    scopus 로고
    • Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial
    • Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285:1711-1718.
    • (2001) JAMA , vol.285 , pp. 1711-1718
    • Schwartz, G.G.1    Olsson, A.G.2    Ezekowitz, M.D.3    Ganz, P.4    Oliver, M.F.5    Waters, D.6
  • 5
    • 16244384606 scopus 로고    scopus 로고
    • Statins and hepatotoxicity: focus on patients with fatty liver
    • Chalasani N. Statins and hepatotoxicity: focus on patients with fatty liver. Hepatology 2005;41:690.
    • (2005) Hepatology , vol.41 , pp. 690
    • Chalasani, N.1
  • 6
    • 70449096299 scopus 로고    scopus 로고
    • Drug-induced liver injury associated with statins
    • Russo MW, Scobey M, Bonkovsky HL. Drug-induced liver injury associated with statins. Semin Liver Dis 2009;29:412-422.
    • (2009) Semin Liver Dis , vol.29 , pp. 412-422
    • Russo, M.W.1    Scobey, M.2    Bonkovsky, H.L.3
  • 7
    • 78649625452 scopus 로고    scopus 로고
    • Drug-induced acute liver failure: results of a U.S. multicenter, prospective study
    • the Acute Liver Failure Study Group.
    • Reuben A, Koch DG, Lee WM, and the Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065-2076.
    • (2010) Hepatology , vol.52 , pp. 2065-2076
    • Reuben, A.1    Koch, D.G.2    Lee, W.M.3
  • 8
    • 84878325626 scopus 로고    scopus 로고
    • Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland
    • Björsson ES, Bergmann OM, Bjornsson HK, Kvaran RB, Olafsson S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013;144:1419-1425.
    • (2013) Gastroenterology , vol.144 , pp. 1419-1425
    • Björsson, E.S.1    Bergmann, O.M.2    Bjornsson, H.K.3    Kvaran, R.B.4    Olafsson, S.5
  • 9
    • 84855970707 scopus 로고    scopus 로고
    • Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing
    • Björnsson E, Jacbosen E, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol 2012;56:374-380.
    • (2012) J Hepatol , vol.56 , pp. 374-380
    • Björnsson, E.1    Jacbosen, E.2    Kalaitzakis, E.3
  • 10
    • 58149347349 scopus 로고    scopus 로고
    • Drug Induced Liver Injury Network (DILIN) prospective study: rationale, design, and conduct
    • Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, et al. Drug Induced Liver Injury Network (DILIN) prospective study: rationale, design, and conduct. Drug Saf 2009;132:55-68.
    • (2009) Drug Saf , vol.132 , pp. 55-68
    • Fontana, R.J.1    Watkins, P.B.2    Bonkovsky, H.L.3    Chalasani, N.4    Davern, T.5    Serrano, J.6
  • 11
    • 57249086242 scopus 로고    scopus 로고
    • Causes, clinical features, and outcomes from a prospective study of drug induced liver injury in the United States
    • Chalasani N, Fontana RJ, Bonkvosky HL, Watkins PB, Davern T, Serrano J, et al. Causes, clinical features, and outcomes from a prospective study of drug induced liver injury in the United States. Gastroenterology 2008;135:1924-1934.
    • (2008) Gastroenterology , vol.135 , pp. 1924-1934
    • Chalasani, N.1    Fontana, R.J.2    Bonkvosky, H.L.3    Watkins, P.B.4    Davern, T.5    Serrano, J.6
  • 14
    • 84893699696 scopus 로고    scopus 로고
    • Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations
    • Kleiner DE, Chalasani N, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB, et al. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology 2014;59:661-670.
    • (2014) Hepatology , vol.59 , pp. 661-670
    • Kleiner, D.E.1    Chalasani, N.2    Lee, W.M.3    Fontana, R.J.4    Bonkovsky, H.L.5    Watkins, P.B.6
  • 16
    • 84904642205 scopus 로고    scopus 로고
    • Accessed on December 1
    • www.livertox.nih.gov. Accessed on December 1, 2013.
    • (2013)
  • 17
    • 0033594789 scopus 로고    scopus 로고
    • Atorvastatin-induced hepatitis with the absence of cross-toxicity with simvastatin
    • Nakad A, Bataille L, Hamoir V, Sempoux C, Horsman Y. Atorvastatin-induced hepatitis with the absence of cross-toxicity with simvastatin. Lancet 1999;353:1763-1764.
    • (1999) Lancet , vol.353 , pp. 1763-1764
    • Nakad, A.1    Bataille, L.2    Hamoir, V.3    Sempoux, C.4    Horsman, Y.5
  • 18
    • 19544375388 scopus 로고    scopus 로고
    • Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization
    • Charles EC, Olson KL, Sandhoff BG, McClure DL, Merenich JA. Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization. Am J Med 2005;118:618-624.
    • (2005) Am J Med , vol.118 , pp. 618-624
    • Charles, E.C.1    Olson, K.L.2    Sandhoff, B.G.3    McClure, D.L.4    Merenich, J.A.5
  • 21
    • 0035991457 scopus 로고    scopus 로고
    • Acute cholestatic hepatitis after reinitiating treatment with atorvastatin
    • Ridruejo E, Mando OG. Acute cholestatic hepatitis after reinitiating treatment with atorvastatin. J Hepatol 2002;37:165-166.
    • (2002) J Hepatol , vol.37 , pp. 165-166
    • Ridruejo, E.1    Mando, O.G.2
  • 22
    • 35048875811 scopus 로고    scopus 로고
    • Marked elevation of liver transaminases after high-dose fluvastatin unmasks chronic hepatitis C: safety and rechallenge
    • Chen YW, Lai HW, Wang TD. Marked elevation of liver transaminases after high-dose fluvastatin unmasks chronic hepatitis C: safety and rechallenge. Acta Neurol Taiwan 2007;16:163-167.
    • (2007) Acta Neurol Taiwan , vol.16 , pp. 163-167
    • Chen, Y.W.1    Lai, H.W.2    Wang, T.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.